Literature DB >> 22212477

Telomere length and iPSC re-programming: survival of the longest.

Richard Allsopp1.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 22212477      PMCID: PMC3317569          DOI: 10.1038/cr.2012.6

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


× No keyword cloud information.
  10 in total

1.  Molecular insights into the heterogeneity of telomere reprogramming in induced pluripotent stem cells.

Authors:  Fang Wang; Yu Yin; Xiaoying Ye; Kai Liu; Haiying Zhu; Lingling Wang; Maria Chiourea; Maja Okuka; Guangzhen Ji; Jiameng Dan; Bingfeng Zuo; Minshu Li; Qian Zhang; Na Liu; Lingyi Chen; Xinghua Pan; Sarantis Gagos; David L Keefe; Lin Liu
Journal:  Cell Res       Date:  2011-12-20       Impact factor: 25.617

2.  Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells.

Authors:  Rosa M Marion; Katerina Strati; Han Li; Agueda Tejera; Stefan Schoeftner; Sagrario Ortega; Manuel Serrano; Maria A Blasco
Journal:  Cell Stem Cell       Date:  2009-02-06       Impact factor: 24.633

3.  Krüppel-like transcription factor 4 contributes to maintenance of telomerase activity in stem cells.

Authors:  Chui-Wei Wong; Pei-Shan Hou; Shun-Fu Tseng; Chung-Liang Chien; Kou-Juey Wu; Hsin-Fu Chen; Hong-Nerng Ho; Satoru Kyo; Shu-Chun Teng
Journal:  Stem Cells       Date:  2010-09       Impact factor: 6.277

4.  Telomere shortening and tumor formation by mouse cells lacking telomerase RNA.

Authors:  M A Blasco; H W Lee; M P Hande; E Samper; P M Lansdorp; R A DePinho; C W Greider
Journal:  Cell       Date:  1997-10-03       Impact factor: 41.582

5.  Severe growth defect in mouse cells lacking the telomerase RNA component.

Authors:  H Niida; T Matsumoto; H Satoh; M Shiwa; Y Tokutake; Y Furuichi; Y Shinkai
Journal:  Nat Genet       Date:  1998-06       Impact factor: 38.330

6.  Reprogramming of human somatic cells to pluripotency with defined factors.

Authors:  In-Hyun Park; Rui Zhao; Jason A West; Akiko Yabuuchi; Hongguang Huo; Tan A Ince; Paul H Lerou; M William Lensch; George Q Daley
Journal:  Nature       Date:  2007-12-23       Impact factor: 49.962

7.  Zscan4 regulates telomere elongation and genomic stability in ES cells.

Authors:  Michal Zalzman; Geppino Falco; Lioudmila V Sharova; Akira Nishiyama; Marshall Thomas; Sung-Lim Lee; Carole A Stagg; Hien G Hoang; Hsih-Te Yang; Fred E Indig; Robert P Wersto; Minoru S H Ko
Journal:  Nature       Date:  2010-03-24       Impact factor: 49.962

8.  Embryonic stem cell lines derived from human blastocysts.

Authors:  J A Thomson; J Itskovitz-Eldor; S S Shapiro; M A Waknitz; J J Swiergiel; V S Marshall; J M Jones
Journal:  Science       Date:  1998-11-06       Impact factor: 47.728

9.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

10.  Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells.

Authors:  Luis F Z Batista; Matthew F Pech; Franklin L Zhong; Ha Nam Nguyen; Kathleen T Xie; Arthur J Zaug; Sharon M Crary; Jinkuk Choi; Vittorio Sebastiano; Athena Cherry; Neelam Giri; Marius Wernig; Blanche P Alter; Thomas R Cech; Sharon A Savage; Renee A Reijo Pera; Steven E Artandi
Journal:  Nature       Date:  2011-05-22       Impact factor: 49.962

  10 in total
  12 in total

1.  Transient delivery of modified mRNA encoding TERT rapidly extends telomeres in human cells.

Authors:  John Ramunas; Eduard Yakubov; Jennifer J Brady; Stéphane Y Corbel; Colin Holbrook; Moritz Brandt; Jonathan Stein; Juan G Santiago; John P Cooke; Helen M Blau
Journal:  FASEB J       Date:  2015-01-22       Impact factor: 5.191

Review 2.  Recent Advances in Tissue Engineering Strategies for the Treatment of Joint Damage.

Authors:  Makeda K Stephenson; Ashley L Farris; Warren L Grayson
Journal:  Curr Rheumatol Rep       Date:  2017-08       Impact factor: 4.592

Review 3.  A Comprehensive Review on the Role of ZSCAN4 in Embryonic Development, Stem Cells, and Cancer.

Authors:  Madhuri Thool; Pradeep Kumar Sundaravadivelu; S Sudhagar; Rajkumar P Thummer
Journal:  Stem Cell Rev Rep       Date:  2022-06-23       Impact factor: 5.739

Review 4.  Mitochondrial DNA Dynamics in Reprogramming to Pluripotency.

Authors:  Alexander J Sercel; Natasha M Carlson; Alexander N Patananan; Michael A Teitell
Journal:  Trends Cell Biol       Date:  2021-04       Impact factor: 21.167

5.  An immortalized human adipose-derived stem cell line with highly enhanced chondrogenic properties.

Authors:  Dakota B Katz; Nguyen P T Huynh; Alireza Savadipour; Ilan Palte; Farshid Guilak
Journal:  Biochem Biophys Res Commun       Date:  2020-08-06       Impact factor: 3.322

6.  Validation of Common Housekeeping Genes as Reference for qPCR Gene Expression Analysis During iPS Reprogramming Process.

Authors:  Yulia Panina; Arno Germond; Shinji Masui; Tomonobu M Watanabe
Journal:  Sci Rep       Date:  2018-06-07       Impact factor: 4.379

Review 7.  T cell senescence and CAR-T cell exhaustion in hematological malignancies.

Authors:  Dimitri Kasakovski; Ling Xu; Yangqiu Li
Journal:  J Hematol Oncol       Date:  2018-07-04       Impact factor: 17.388

8.  Reprogramming of mouse fibroblasts into neural lineage cells using biomaterials.

Authors:  Fahsai Kantawong; Chanidapa Saksiriwisitkul; Chanakan Riyapa; Suchalinee Limpakdee; Phenphichar Wanachantararak; Thasaneeya Kuboki
Journal:  Bioimpacts       Date:  2018-01-10

Review 9.  The Evolving Role of CD8+CD28- Immunosenescent T Cells in Cancer Immunology.

Authors:  Wei X Huff; Jae Hyun Kwon; Mario Henriquez; Kaleigh Fetcko; Mahua Dey
Journal:  Int J Mol Sci       Date:  2019-06-08       Impact factor: 5.923

Review 10.  Application of Chimeric Antigen Receptor T Cells in the Treatment of Hematological Malignancies.

Authors:  Weiqi Yan; Zhuojun Liu; Jia Liu; Yuanshi Xia; Kai Hu; Jian Yu
Journal:  Biomed Res Int       Date:  2020-10-01       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.